Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Penile Neoplasms 1Condylomata Acuminata 1Anus Neoplasms 1

Interventions

Mitomycin 5Specimen Handling 4Nivolumab 4Magnetic Resonance Spectroscopy 4Fluorouracil 4Capecitabine 4Biopsy 4pembrolizumab 3Drug Therapy 3dehydroftorafur 2Vaccines 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Radiation 2Proctoscopy 2Mitozytrex 2Fluorodeoxyglucose F18 2Colonoscopy 2tislelizumab 1spartalizumab 1entinostat 1durvalumab 1bintrafusp alfa protein, human 1X-Rays 1Watchful Waiting 1Vaccines, Synthetic 1Tomography, X-Ray Computed 1Taxes 1Surveys and Questionnaires 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Anus Neoplasms × Vaccines, Synthetic × Clear all
NCT06465914 2024-12-12

A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Shanghai Bovax Biotechnology Co., Ltd.

Phase 3 Active not recruiting
9,000 enrolled
GastrointestinalGenitourinary

Anus Neoplasms, Condylomata Acuminata, Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡